Table 2.
Prevalence Ratios for the Associations of Gender With Retention in Care and Viral Suppression—North American AIDS Cohort Collaboration on Research and Design, 2014
| Gender | N | % | PRa | 95% CI | aPRb | 95% CI |
|---|---|---|---|---|---|---|
| Retained in Care (N = 23 354) | ||||||
| Transgender women | 151 | 1 | 1.00 | [.92, 1.10] | 0.99 | [.90, 1.08] |
| Cisgender women | 4731 | 20 | 1.05 | [1.04, 1.07] | 1.03 | [1.02, 1.05] |
| Cisgender men | 18 427 | 79 | Ref | … | Ref | … |
| Suppressed (≤200 copies/mL) Human Immunodeficiency Virus Viral Load (N = 26 355) | ||||||
| Transgender women | 173 | 1 | 0.93 | [.86, .99] | 0.96 | [.89, 1.02] |
| Cisgender women | 5171 | 20 | 0.96 | [.95, .98] | 1.00 | [.98, 1.01] |
| Cisgender men | 21 011 | 80 | Ref | … | Ref | … |
Bold signifies the 95% CI does not include 1.0.
Abbreviations: aPR, adjusted prevalence ratio; CI, confidence interval; PR, prevalence ratio; Ref, Reference category.
aThe PRs and 95% CIs were estimated using a log-binomial regression model.
bThe aPRs and 95% CIs were estimated using a log-binomial regression model (for retention in care) and a Poisson regression with robust variance model (for viral suppression) accounting for age, race/ethnicity, human immunodeficiency virus risk group, and cohort.